Promega builds plant to produce regulated products

Published: 29-Aug-2011
Manufacturing Analysis

Including sample preparation systems and reagents

Promega Corporation, based in Madison, Wisconsin, US, has held a ground-breaking ceremony for a new cGMP facility to support business growth and customers who need FDA-regulated molecular biology products. These include sample preparation systems and reagents, which are part of diagnostic and medical tests sold by human diagnostic test providers.

The 260,000ft2 (24,150m2) facility will require an additional 100 people in the next five years. Most of the building will be dedicated to fixed and flexible manufacturing areas. It will also house a customer experience centre for training, laboratory demonstrations and conferences.

‘This building is our next step in expanding our product supply capabilities worldwide,’ said ceo Bill Linton.

Plans include a number of sustainable practices, including geothermal heating and cooling, dark sky compliant lighting, prairie restoration, bio-retention ponds for storm water run off among other sustainable features and construction practices.

Promega Corporation provides solutions and technical support to the life sciences industry. Its 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.

See more

You may also like

Ingredients

Promega unveils cellular target engagement technology

Read more
TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery

Trending Articles

  1. Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
  2. Labtex - Fresh thinking and innovative solutions Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
  3. Shimadzu celebrates a 70th anniversary Gas chromatography (GC) product line celebrates 70th anniversary, European and world premieres underscore progress in laboratory analytics
  4. Degasser for volatile and aggressive solvents Biotech Fluidics announce the DEGASi Integration HFIP - a high-performance online system designed to efficiently degas even the toughest solvents. This unique degasser is fully compatible with a wide range of volatile and aggressive liquids including Hexafluoroisopropanol (HFIP) and silanes but can also manage all other solvents used for GPC/SEC and HPLC
  5. Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site The duo will integrate the SHL's Molly autoinjector platform into Thermo's Ridgefield, New Jersey facility, creating an end-to-end US-based solution for drug-device combination products spanning sterile manufacturing, device assembly and commercial packaging

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Ingredients

Promega unveils cellular target engagement technology

TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
Manufacturing

Promega opens new Shanghai facility

Provides additional r&d and cGMP manufacturing capabilities
Manufacturing

Freudenberg Medical launches CleanAssure ISO Class 5 cleanroom service for sterile single-use biopharma assemblies

CleanAssure is an ISO Class 5 controlled cleanroom service delivering washed, dried and gamma-sterilised single-use assemblies to biopharmaceutical customers, addressing industry challenges around cleaning validation and contamination risk
Regulatory

Ion chromatography in pharmaceutical analysis: a long road to acceptance

John Welch, Associate Director, Butterworth Laboratories, writes on how ion chromatography evolved into a mature and widely adopted pharmaceutical analysis technique
Manufacturing

Step into Cognitive Manufacturing: Step into IMA Digital Ecosystem

At Interpack 2026, IMA invites you on a journey through an entire pavilion transformed into a living, breathing expression of what the Group calls Cognitive Manufacturing
Manufacturing

Mabwell signs Malaysia licensing deal for denosumab biosimilars MAILISHU and MAIWEIJIAN

Mabwell has entered a licensing and commercialisation agreement to bring its denosumab biosimilars to Malaysia, supporting regional access through local registration and supply of its Prolia and Xgeva reference products
Regulatory

Implementing compendial methods to minimise testing risk

Understanding feasibility testing and verification to ensure reliable analytical results
Subscribe now